| O87 | Name: | 4-{4-[3-(trifluoromethyl)phenyl]piperazine-1-carbonyl}quinolin-2(1H)-one | Formula: | C21 H18 F3 N3 O2 | SMILES: | O=C(C1=CC(=O)Nc2ccccc21)N1CCN(CC1)c1cc(ccc1)C(F)(F)F | InChi: | InChI=1S/C21H18F3N3O2/c22-21(23,24)14-4-3-5-15(12-14)26-8-10-27(11-9-26)20(29)17-13-19(28)25-18-7-2-1-6-16(17)18/h1-7,12-13H,8-11H2,(H,25,28) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 4-{4-[3-(trifluoromethyl)phenyl]piperazine-1-carbonyl}quinolin-2(1H)-one |
|
| O8L | Name: | (2S)-2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C18 H18 Cl N3 O3 | SMILES: | Cc1ccncc1NC(=O)C(C)c1cc(Cl)cc(OC2CC(=O)N2)c1 | InChi: | InChI=1S/C18H18ClN3O3/c1-10-3-4-20-9-15(10)21-18(24)11(2)12-5-13(19)7-14(6-12)25-17-8-16(23)22-17/h3-7,9,11,17H,8H2,1-2H3,(H,21,24)(H,22,23)/t11-,17+/m0/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2S)-2-(3-chloro-5-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-N-(4-methylpyridin-3-yl)propanamide |
|
| 9WV | Name: | beta-alanyl-3-amino-L-alanine | Formula: | C6 H13 N3 O3 | SMILES: | NCC(NC(=O)CCN)C(O)=O | InChi: | InChI=1S/C6H13N3O3/c7-2-1-5(10)9-4(3-8)6(11)12/h4H,1-3,7-8H2,(H,9,10)(H,11,12)/t4-/m0/s1 | Definition date: | 2017-06-20 | Last modified: | 2023-11-03 | Release date: | 2017-10-04 | Identifier: | beta-alanyl-3-amino-L-alanine |
|
| O9O | Name: | N-{3-chloro-5-[(6-methoxypyridin-2-yl)oxy]phenyl}-2-(isoquinolin-4-yl)acetamide | Formula: | C23 H18 Cl N3 O3 | SMILES: | COc1cccc(Oc2cc(NC(=O)Cc3cncc4ccccc43)cc(Cl)c2)n1 | InChi: | InChI=1S/C23H18ClN3O3/c1-29-22-7-4-8-23(27-22)30-19-11-17(24)10-18(12-19)26-21(28)9-16-14-25-13-15-5-2-3-6-20(15)16/h2-8,10-14H,9H2,1H3,(H,26,28) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-{3-chloro-5-[(6-methoxypyridin-2-yl)oxy]phenyl}-2-(isoquinolin-4-yl)acetamide |
|
| O9X | Name: | (2R)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C10 H12 F2 N2 O2 | SMILES: | O=C(Nc1cnccc1C)C(C)OC(F)F | InChi: | InChI=1S/C10H12F2N2O2/c1-6-3-4-13-5-8(6)14-9(15)7(2)16-10(11)12/h3-5,7,10H,1-2H3,(H,14,15)/t7-/m1/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2R)-2-(difluoromethoxy)-N-(4-methylpyridin-3-yl)propanamide |
|
| 9XQ | Name: | [azanyl-[(3-carboxyphenyl)amino]methylidene]azanium | Formula: | C8 H10 N3 O2 | SMILES: | NC(=[NH2+])Nc1cccc(c1)C(O)=O | InChi: | InChI=1S/C8H9N3O2/c9-8(10)11-6-3-1-2-5(4-6)7(12)13/h1-4H,(H,12,13)(H4,9,10,11)/p+1 | Definition date: | 2017-07-27 | Last modified: | 2023-11-03 | Release date: | 2018-06-06 | Identifier: | [azanyl-[(3-carboxyphenyl)amino]methylidene]azanium |
|
| OAO | Name: | 2-{3-chloro-5-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl}-N-(4-methylpyridin-3-yl)acetamide | Formula: | C18 H17 Cl N4 O3 | SMILES: | Cc1nc(COc2cc(CC(=O)Nc3cnccc3C)cc(Cl)c2)on1 | InChi: | InChI=1S/C18H17ClN4O3/c1-11-3-4-20-9-16(11)22-17(24)7-13-5-14(19)8-15(6-13)25-10-18-21-12(2)23-26-18/h3-6,8-9H,7,10H2,1-2H3,(H,22,24) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-{3-chloro-5-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl}-N-(4-methylpyridin-3-yl)acetamide |
|
| OAR | Name: | N-(4-AMINO-5-HYDROXY-PENTYL)-GUANIDINE | Formula: | C6 H16 N4 O | SMILES: | [N@H]=C(NCCCC(N)CO)N | InChi: | InChI=1S/C6H16N4O/c7-5(4-11)2-1-3-10-6(8)9/h5,11H,1-4,7H2,(H4,8,9,10)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 1-[(4S)-4-amino-5-hydroxypentyl]guanidine |
|
| OAS | Name: | O-ACETYLSERINE | Formula: | C5 H9 N O4 | SMILES: | O=C(OCC(N)C(=O)O)C | InChi: | InChI=1S/C5H9NO4/c1-3(7)10-2-4(6)5(8)9/h4H,2,6H2,1H3,(H,8,9)/t4-/m0/s1 | Definition date: | 2000-02-01 | Last modified: | 2023-11-03 | Identifier: | O-acetyl-L-serine |
|
| OBF | Name: | (2S)-2-amino-4,4-difluorobutanoic acid | Formula: | C4 H7 F2 N O2 | SMILES: | FC(F)CC(N)C(=O)O | InChi: | InChI=1S/C4H7F2NO2/c5-3(6)1-2(7)4(8)9/h2-3H,1,7H2,(H,8,9)/t2-/m0/s1 | Definition date: | 2008-03-14 | Last modified: | 2023-11-03 | Identifier: | (2S)-2-amino-4,4-difluorobutanoic acid |
|
| OBO | Name: | 2-(3-chlorophenyl)-N-(1H-imidazo[4,5-c]pyridin-7-yl)acetamide | Formula: | C14 H11 Cl N4 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2nc[NH]c12 | InChi: | InChI=1S/C14H11ClN4O/c15-10-3-1-2-9(4-10)5-13(20)19-12-7-16-6-11-14(12)18-8-17-11/h1-4,6-8H,5H2,(H,17,18)(H,19,20) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1H-imidazo[4,5-c]pyridin-7-yl)acetamide |
|
| OBS | Name: | (Z)-N^6-[(4S,5R)-5-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)-1-HYDROXYDIHYDRO-2H-THIOPYRANIUM-3(4H)-YLIDENE]-L-LYSINE | Formula: | C16 H26 N2 O7 S | SMILES: | O=S1C/C(=N/CCCCC(C(=O)O)N)C(C(CCC(=O)O)C1)CC(=O)O | InChi: | InChI=1S/C16H26N2O7S/c17-12(16(23)24)3-1-2-6-18-13-9-26(25)8-10(4-5-14(19)20)11(13)7-15(21)22/h10-12H,1-9,17H2,(H,19,20)(H,21,22)(H,23,24)/b18-13-/t10-,11-,12+,26+/m1/s1 | Synonyms: | 2-AMINO-6-[5-(2-CARBOXY-ETHYL)-4-CARBOXYMETHYL-1-OXO-TETRAHYDRO-1LAMBDA4-THIOPYRAN-3-YLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2023-11-03 | Identifier: | (E)-N~6~-[(1S,4R,5S)-5-(2-carboxyethyl)-4-(carboxymethyl)-1-oxidodihydro-2H-thiopyran-3(4H)-ylidene]-L-lysine |
|
| OCE | Name: | octanedioic acid | Formula: | C8 H14 O4 | SMILES: | O=C(O)CCCCCCC(=O)O | InChi: | InChI=1S/C8H14O4/c9-7(10)5-3-1-2-4-6-8(11)12/h1-6H2,(H,9,10)(H,11,12) | Definition date: | 2010-05-26 | Last modified: | 2023-11-03 | Identifier: | octanedioic acid |
|
| OCI | Name: | 2-(3-chloro-5-sulfamamidophenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C14 H15 Cl N4 O3 S | SMILES: | O=C(Nc1cnccc1C)Cc1cc(NS(N)(=O)=O)cc(Cl)c1 | InChi: | InChI=1S/C14H15ClN4O3S/c1-9-2-3-17-8-13(9)18-14(20)6-10-4-11(15)7-12(5-10)19-23(16,21)22/h2-5,7-8,19H,6H2,1H3,(H,18,20)(H2,16,21,22) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-sulfamamidophenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| OCQ | Name: | (3S)-3-[(2S)-2-AMINO-4-HYDROXY-3-OXOBUTYL]PYRROLIDIN-2-ONE | Formula: | C8 H14 N2 O3 | SMILES: | O=C1NCCC1CC(N)C(=O)CO | InChi: | InChI=1S/C8H14N2O3/c9-6(7(12)4-11)3-5-1-2-10-8(5)13/h5-6,11H,1-4,9H2,(H,10,13)/t5-,6-/m0/s1 | Definition date: | 2007-06-07 | Last modified: | 2023-11-03 | Identifier: | (3S)-3-[(2S)-2-amino-4-hydroxy-3-oxobutyl]pyrrolidin-2-one |
|
| OCS | Name: | CYSTEINESULFONIC ACID | Formula: | C3 H7 N O5 S | SMILES: | O=S(=O)(O)CC(C(=O)O)N | InChi: | InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | 3-sulfo-L-alanine |
|
| A0A | Name: | (2S)-2-AMINO-4-(FORMYLOXY)-4-OXOBUTANOIC ACID | Formula: | C5 H7 N O5 | SMILES: | O=C(OC=O)CC(C(=O)O)N | InChi: | InChI=1S/C5H7NO5/c6-3(5(9)10)1-4(8)11-2-7/h2-3H,1,6H2,(H,9,10)/t3-/m0/s1 | Definition date: | 2007-12-11 | Last modified: | 2023-11-03 | Identifier: | (2S)-2-amino-4-(formyloxy)-4-oxobutanoic acid (non-preferred name) |
|
| OCY | Name: | HYDROXYETHYLCYSTEINE | Formula: | C5 H11 N O3 S | SMILES: | O=C(O)C(N)CSCCO | InChi: | InChI=1S/C5H11NO3S/c6-4(5(8)9)3-10-2-1-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2023-11-03 | Identifier: | S-(2-hydroxyethyl)-L-cysteine |
|
| A0G | Name: | (2Z)-2-amino-3-hydroxyprop-2-enoic acid | Formula: | C3 H5 N O3 | SMILES: | C(=O)(/C(N)=C/O)O | InChi: | InChI=1S/C3H5NO3/c4-2(1-5)3(6)7/h1,5H,4H2,(H,6,7)/b2-1- | Definition date: | 2017-06-30 | Last modified: | 2023-11-03 | Release date: | 2019-09-18 | Identifier: | (2Z)-2-amino-3-hydroxyprop-2-enoic acid |
|
| OD7 | Name: | 2-(6-methoxy-1H-benzotriazol-1-yl)-N-[4-(piperidin-4-yl)phenyl]-N-[(pyridin-2-yl)methyl]acetamide | Formula: | C26 H28 N6 O2 | SMILES: | COc1ccc2nnn(CC(=O)N(Cc3ccccn3)c3ccc(cc3)C3CCNCC3)c2c1 | InChi: | InChI=1S/C26H28N6O2/c1-34-23-9-10-24-25(16-23)32(30-29-24)18-26(33)31(17-21-4-2-3-13-28-21)22-7-5-19(6-8-22)20-11-14-27-15-12-20/h2-10,13,16,20,27H,11-12,14-15,17-18H2,1H3 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(6-methoxy-1H-benzotriazol-1-yl)-N-[4-(piperidin-4-yl)phenyl]-N-[(pyridin-2-yl)methyl]acetamide |
|
| ODA | Name: | 9-AMINO-6,10-DIOXO-OCTAHYDRO-PYRIDAZINO[1,2-A][1,2]DIAZEPINE-1-CARBOXYLIC ACID | Formula: | C10 H15 N3 O4 | SMILES: | O=C(O)C2N1C(=O)C(N)CCC(=O)N1CCC2 | InChi: | InChI=1S/C10H15N3O4/c11-6-3-4-8(14)12-5-1-2-7(10(16)17)13(12)9(6)15/h6-7H,1-5,11H2,(H,16,17)/t6-,7-/m0/s1 | Definition date: | 1999-10-14 | Last modified: | 2023-11-03 | Identifier: | (1S,9S)-9-amino-6,10-dioxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid |
|
| ODX | Name: | 2-(3-chloro-5-{[(1S,2S)-2-hydroxycyclopentyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C19 H22 Cl N3 O2 | SMILES: | O=C(Nc1cnccc1C)Cc1cc(NC2CCCC2O)cc(Cl)c1 | InChi: | InChI=1S/C19H22ClN3O2/c1-12-5-6-21-11-17(12)23-19(25)9-13-7-14(20)10-15(8-13)22-16-3-2-4-18(16)24/h5-8,10-11,16,18,22,24H,2-4,9H2,1H3,(H,23,25)/t16-,18-/m0/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-{[(1S,2S)-2-hydroxycyclopentyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| A1G | Name: | (2S)-amino[(3R,5R,7R)-tricyclo[3.3.1.1~3,7~]decan-1-yl]acetic acid | Formula: | C12 H19 N O2 | SMILES: | O=C(O)C(C13CC2CC(C1)CC(C2)C3)N | InChi: | InChI=1S/C12H19NO2/c13-10(11(14)15)12-4-7-1-8(5-12)3-9(2-7)6-12/h7-10H,1-6,13H2,(H,14,15)/t7-,8+,9-,10-,12-/m1/s1 | Definition date: | 2016-04-28 | Last modified: | 2023-11-03 | Release date: | 2017-05-10 | Identifier: | (2S)-amino[(3R,5R,7R)-tricyclo[3.3.1.1~3,7~]decan-1-yl]acetic acid |
|
| OE6 | Name: | N-(1H-benzotriazol-1-yl)-2-(3-chlorophenyl)acetamide | Formula: | C14 H11 Cl N4 O | SMILES: | Clc1cccc(c1)CC(=O)Nn1nnc2ccccc21 | InChi: | InChI=1S/C14H11ClN4O/c15-11-5-3-4-10(8-11)9-14(20)17-19-13-7-2-1-6-12(13)16-18-19/h1-8H,9H2,(H,17,20) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(1H-benzotriazol-1-yl)-2-(3-chlorophenyl)acetamide |
|
| OEM | Name: | N-methyl-D-aspartic acid | Formula: | C5 H9 N O4 | SMILES: | O=C(O)C(NC)CC(=O)O | InChi: | InChI=1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 | Definition date: | 2010-08-17 | Last modified: | 2023-11-03 | Identifier: | N-methyl-D-aspartic acid |
|